Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
Clinical trial NCT06303128 · RECRUITING
Trial details
- NCT number
- NCT06303128
- Sponsor
- James Tarbox, MD
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-03
- Primary completion
- 2026-07-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.